Subscribe
shutterstock_1524542537_michael_vi
Michael Vi / Shutterstock.com
24 August 2021MedtechAlex Baldwin

Fed Circ upholds challenge to J&J robot patent

The US Court of Appeals for the Federal Circuit has invalidated more claims of a Johnson & Johnson (J&J) subsidiary’s surgical robot patent following a cross-appeal of a Patent Trial and Appeal Board (PTAB) decision.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
J&J units launch prostate cancer drug suit
31 May 2022   Johnson & Johnson subsidiaries Aragon Pharmaceuticals and Janssen Biotech have sued three pharma companies for alleged infringement of five patents relating to prostate cancer treatment Erleada.
Medtech
Fed Circuit revives bid to invalidate robotic surgery patent
3 May 2022   The US Court of Appeals for the Federal Circuit has renewed Auris Health’s attempt to invalidate Intuitive Surgical’s patent covering a robotic surgical tool.
Medtech
Fed Circ denies bid to reverse favourable J&J ruling
15 February 2022   The US Court of Appeals for the Federal Circuit has affirmed two Patent Trial and Appeal Board rulings that a Johnson & Johnson subsidiary’s patent is valid and infringed.


Editor's picks

Life sciences leaders recognised at LSPN Awards USA 2025
Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

Editor's picks

Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

More on this story

Americas
J&J units launch prostate cancer drug suit
31 May 2022   Johnson & Johnson subsidiaries Aragon Pharmaceuticals and Janssen Biotech have sued three pharma companies for alleged infringement of five patents relating to prostate cancer treatment Erleada.
Medtech
Fed Circuit revives bid to invalidate robotic surgery patent
3 May 2022   The US Court of Appeals for the Federal Circuit has renewed Auris Health’s attempt to invalidate Intuitive Surgical’s patent covering a robotic surgical tool.
Medtech
Fed Circ denies bid to reverse favourable J&J ruling
15 February 2022   The US Court of Appeals for the Federal Circuit has affirmed two Patent Trial and Appeal Board rulings that a Johnson & Johnson subsidiary’s patent is valid and infringed.

More on this story

Americas
J&J units launch prostate cancer drug suit
31 May 2022   Johnson & Johnson subsidiaries Aragon Pharmaceuticals and Janssen Biotech have sued three pharma companies for alleged infringement of five patents relating to prostate cancer treatment Erleada.
Medtech
Fed Circuit revives bid to invalidate robotic surgery patent
3 May 2022   The US Court of Appeals for the Federal Circuit has renewed Auris Health’s attempt to invalidate Intuitive Surgical’s patent covering a robotic surgical tool.
Medtech
Fed Circ denies bid to reverse favourable J&J ruling
15 February 2022   The US Court of Appeals for the Federal Circuit has affirmed two Patent Trial and Appeal Board rulings that a Johnson & Johnson subsidiary’s patent is valid and infringed.

More features

Life sciences leaders recognised at LSPN Awards USA 2025
UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body
LSPN: Counsel grapple with AI’s impact on training and critical thinking
'Nothing can stand in the way of our work': Ukraine resumes IP system
LSPN: Trump's policy storm causing chaos and confusion
Taylor Wessing expands in Europe with Paris team
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
ResMed voids sleep apnoea tech patent at PTAB